DZ2311A1 - Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives. - Google Patents
Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives.Info
- Publication number
- DZ2311A1 DZ2311A1 DZ970161A DZ970161A DZ2311A1 DZ 2311 A1 DZ2311 A1 DZ 2311A1 DZ 970161 A DZ970161 A DZ 970161A DZ 970161 A DZ970161 A DZ 970161A DZ 2311 A1 DZ2311 A1 DZ 2311A1
- Authority
- DZ
- Algeria
- Prior art keywords
- preparation
- degenerative diseases
- benzopyran derivatives
- medicaments against
- against degenerative
- Prior art date
Links
- 150000001562 benzopyrans Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ2311A1 true DZ2311A1 (fr) | 2002-12-28 |
Family
ID=10800127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ970161A DZ2311A1 (fr) | 1996-09-18 | 1997-09-17 | Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives. |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0939630B1 (de) |
| JP (1) | JP2001500520A (de) |
| KR (1) | KR20000036184A (de) |
| CN (1) | CN1230885A (de) |
| AP (1) | AP9901473A0 (de) |
| AR (1) | AR008838A1 (de) |
| AT (1) | ATE270102T1 (de) |
| AU (1) | AU730465B2 (de) |
| BG (1) | BG103252A (de) |
| BR (1) | BR9712030A (de) |
| CA (1) | CA2266681A1 (de) |
| DE (1) | DE69729735T2 (de) |
| DZ (1) | DZ2311A1 (de) |
| EA (1) | EA199900306A1 (de) |
| ES (1) | ES2223075T3 (de) |
| GB (1) | GB9619492D0 (de) |
| HU (1) | HUP9904638A3 (de) |
| ID (2) | ID23175A (de) |
| IL (1) | IL128786A0 (de) |
| MA (1) | MA24321A1 (de) |
| NO (1) | NO991292D0 (de) |
| NZ (1) | NZ334271A (de) |
| OA (1) | OA10998A (de) |
| PE (1) | PE109898A1 (de) |
| PL (1) | PL332313A1 (de) |
| SK (1) | SK35199A3 (de) |
| TR (1) | TR199900527T2 (de) |
| UY (1) | UY24717A1 (de) |
| WO (1) | WO1998011890A1 (de) |
| ZA (1) | ZA978359B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| US20130281524A1 (en) * | 2008-06-05 | 2013-10-24 | Peter Blower | Novel treatments |
| MX2010013312A (es) * | 2008-06-05 | 2011-05-30 | Minster Res Ltd | Tratamientos novedoos. |
| ES2642586T3 (es) | 2009-07-27 | 2017-11-16 | Gilead Sciences, Inc. | Compuestos heterocíclicos condensados como moduladores de canales iónicos |
| US20130018091A1 (en) * | 2009-12-03 | 2013-01-17 | Peter Blower | Treatment of allodynia and hyperalgesia |
| EP2506847A1 (de) * | 2009-12-03 | 2012-10-10 | Proximagen Limited | Behandlung von infektionserkrankungen |
| EP2588197B1 (de) | 2010-07-02 | 2014-11-05 | Gilead Sciences, Inc. | Kondensierte heterozyklische verbindungen als ionenkanalmodulatoren |
| KR20140033377A (ko) | 2011-05-10 | 2014-03-18 | 길리애드 사이언시즈, 인코포레이티드 | 나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물 |
| NO3175985T3 (de) | 2011-07-01 | 2018-04-28 | ||
| UY34171A (es) | 2011-07-01 | 2013-01-31 | Gilead Sciences Inc | Compuestos heterocíclicos fusionados como moduladores del canal iónico |
| CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
| CN1174975C (zh) * | 1994-06-10 | 2004-11-10 | 史密丝克莱恩比彻姆有限公司 | 苯并吡喃类化合物和它们作为治疗剂的用途 |
| GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Withdrawn
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Ceased
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 EP EP97909300A patent/EP0939630B1/de not_active Expired - Lifetime
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292D0/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0939630A1 (de) | 1999-09-08 |
| AR008838A1 (es) | 2000-02-23 |
| AU730465B2 (en) | 2001-03-08 |
| BG103252A (en) | 1999-09-30 |
| HUP9904638A2 (hu) | 2001-05-28 |
| JP2001500520A (ja) | 2001-01-16 |
| EA199900306A1 (ru) | 1999-08-26 |
| PL332313A1 (en) | 1999-08-30 |
| SK35199A3 (en) | 2000-07-11 |
| MA24321A1 (fr) | 1998-04-01 |
| ATE270102T1 (de) | 2004-07-15 |
| CA2266681A1 (en) | 1998-03-26 |
| ZA978359B (en) | 1999-03-17 |
| UY24717A1 (es) | 2001-08-27 |
| HUP9904638A3 (en) | 2001-08-28 |
| AU4704797A (en) | 1998-04-14 |
| PE109898A1 (es) | 1999-03-21 |
| BR9712030A (pt) | 1999-08-24 |
| KR20000036184A (ko) | 2000-06-26 |
| CN1230885A (zh) | 1999-10-06 |
| AP9901473A0 (en) | 1999-03-31 |
| TR199900527T2 (xx) | 1999-06-21 |
| EP0939630B1 (de) | 2004-06-30 |
| ES2223075T3 (es) | 2005-02-16 |
| NO991292L (no) | 1999-03-17 |
| WO1998011890A1 (en) | 1998-03-26 |
| GB9619492D0 (en) | 1996-10-30 |
| ID23175A (id) | 2000-03-23 |
| DE69729735T2 (de) | 2005-07-14 |
| ID19542A (id) | 1998-07-23 |
| DE69729735D1 (de) | 2004-08-05 |
| NO991292D0 (no) | 1999-03-17 |
| NZ334271A (en) | 2001-03-30 |
| OA10998A (en) | 2003-03-04 |
| IL128786A0 (en) | 2000-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2053597A (en) | Pharmaceutical compositions for the treatment of glaucoma | |
| HUP9601566A2 (en) | Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component | |
| IL132296A0 (en) | Substituted benzopyran derivatives for the treatment of inflammation | |
| HUP0003311A3 (en) | Substituted 6-phenylphenanthridine derivatives, pocess for producing them and pharmaceutical compositions containing them | |
| AU1774097A (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| IL116746A0 (en) | Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| HUP9901326A3 (en) | Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions | |
| DZ2311A1 (fr) | Utilisation de dérivés de benzopyranne et analogues pour la préparation de médicaments contre des maladies dégénératives. | |
| MX15184A (es) | Procedimiento para la preparacion de derivados de isoindolinona,compuesto obtenido y medicamento quelo incluye. | |
| AU7000796A (en) | Heteroaryl-substituted acryloylguanidine derivatives and pharmaceutical compositions comprising them | |
| DZ2308A1 (fr) | Procédés et intermédiaires pour la préparation de dérivés de chromanol substitués. | |
| HUP0003398A3 (en) | Novel triptolide derivatives and pharmaceutical compositions thereof | |
| AU2773597A (en) | Pharmaceutical compositions for the sustained release of insoluble active principles | |
| HUP0004648A3 (en) | 3-substituted tetrahydropyridopyrimidinone derivatives and their use for producing pharmaceutical compositions | |
| IL116828A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| IL116745A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| AU8553898A (en) | Use of 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions to treat diseases connected with the endogenous opioid system | |
| ZA97872B (en) | Use of pyrolidine derivatives for the manufacture of medicaments. | |
| HUP9800631A3 (en) | 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions | |
| IL116826A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| AU6582098A (en) | Medical splint product | |
| IL116747A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
| HUP9904181A3 (en) | Sufrace-stabilised pharmaceutical preparation for application on the skin | |
| HUP0000966A3 (en) | Isoflavone derivatives and pharmaceutical compositions containing them | |
| IL127690A0 (en) | Pyridinocyclohexano-1,3- pyrimidine derivatives their preparation their use as medicaments and pharmaceutical formulations including them |